Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12944-015-0006-5
Published Online: 2015-02-18
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Meyers, Charles Daniel
Tremblay, Karine
Amer, Ahmed
Chen, Jin
Jiang, Liewen
Gaudet, Daniel
License valid from 2015-02-18
Article History
Received: 8 September 2014
Accepted: 28 January 2015
First Online: 18 February 2015